Comparative preclinical toxicology and pharmacology of isophosphoramide mustard, the active metabolite of ifosfamide |
| |
Authors: | Germann N Urien S Rodgers Andrew H Ratterree Marion Struck Robert F Waud William R Serota David G Bastian Gerard Jursic Branko S Morgan Lee Roy |
| |
Affiliation: | (1) Service de pharmacology, Centre René Huguenin, 35 rue Dailly, 92210 Saint Cloud, France;(2) DEKK-TEC, Inc., 4200 Canal Street, New Orleans, LA 70119, USA;(3) Delta Primate Center, Tulane University, Covington, LA 70433, USA;(4) Southern Research Institute, Birmingham, AL 35205, USA;(5) MPI Research, Mattawan, MI 49071, USA;(6) University of New Orleans, New Orleans, LA 70119, USA |
| |
Abstract: | Background Isophosphoramide mustard (IPM) is the cytotoxic alkylating metabolite of Ifosfamide (IFOS). IPM is being readied for a phase I clinical trial. In the present preclinical study, IPM was evaluated for usage in multidose intravenous (IV) infusion protocols.Methods Mice and dogs received IV IPM daily for 3 days. Single-day dosing—oral and IV—to mice, rats, and monkeys is also reviewed for comparison. Complete toxicology studies were completed in the mice and dogs. For mice, dogs and monkeys, IV pharmacokinetic studies were conducted and compared.Results For mice, the LD10 for the 3-day IV schedule for IPM was calculated to be 119 mg/kg (with 95% confidence limits of 87–134 mg/kg) (combined sexes), and for adult male dogs the maximum tolerated dose (MTD) was 5 mg/kg. Pharmacokinetic studies in mice, dogs and monkeys were compared and projected to human dosing. For dogs that received 10 mg/kg of IPM, T1/2 was 0.99 h, and clearance was constant (1.01 l/h/kg). IPM was detected from 0 h to 1.5 h after the 5 mg/kg dose and from 0 h to 2 h after the 10 mg/kg dose; none was detected after 2 h. The IV MTD in dogs was 5 mg/kg per day for 3 days. Renal tubular necrosis and bone marrow failure were the causes of death. Transient liver, renal and bone marrow toxicity and gastrointestinal dysfunction were seen at low doses (<5 mg/kg) in dogs. In mice (receiving 100 mg/kg IV) plasma concentrations disappeared in less than 1 h (T1/2 2 min), with a clearance of 8.44 l/h/kg. For monkeys, the mean T1/2 was 4.2 h. Median clearance was 1.65 l/h/kg and no IPM was detected 4 h after dosing. No potential IPM metabolites could be detected in any of the studies. In vitro, plasma protein bound 90% of IPM within 5 min of incubation.Conclusions Predictions for human pharmacokinetic parameters and dosing are made from allometric analysis using the above three species. Data predicted an acceptable starting dose of 30 mg/m2 with a clearance of 39.5 l/h, and a T1/2 of 1 h 45 min for a 70-kg patient. |
| |
Keywords: | Isophosphoramide mustard Pharmacology/toxicology Mice Rat Dogs Monkey |
本文献已被 PubMed SpringerLink 等数据库收录! |
|